Search Results for: Ct

A Multicenter, Open-label, Randomized (1:1) Trial Designed to Evaluate Whether MRD-guided Intermittent ICI Therapy Provides Comparable Survival to SOC Continuous ICI Therapy in Subjects With Histologically Confirmed Advanced / Metastatic NSCLC, Melanoma, MSI-High/dMMR CRC, RCC and Other Solid Tumors.

A Multicenter, Open-label, Randomized (1:1) Trial Designed to Evaluate Whether MRD-guided Intermittent ICI Therapy Provides Comparable Survival to SOC Continuous ICI Therapy in Subjects With Histologically Confirmed Advanced / Metastatic NSCLC, Melanoma, MSI-High/dMMR CRC, RCC and Other Solid Tumors.

Melanoma News
Publication date: Jul 01, 2026 This is an open-label, randomized study evaluating whether MRD-guided intermittent ICI therapy provides comparable survival to SOC continuous ICI therapy in subjects with histologically confirmed ... Read more